€10.06
1.62% today
Frankfurt, Apr 01, 08:08 am CET
ISIN
SE0017769995
Symbol
BGLA
Sector
Industry

BioGaia Stock price

€9.90
-1.12 10.16% 1M
+0.06 0.61% 6M
+0.25 2.59% YTD
-1.14 10.32% 1Y
+0.08 0.85% 3Y
+2.89 41.29% 5Y
+6.17 165.66% 10Y
Frankfurt, Closing price Mon, Mar 31 2025
+0.01 0.05%
ISIN
SE0017769995
Symbol
BGLA
Sector
Industry

Key metrics

Market capitalization €1.00b
Enterprise Value €894.52m
P/E (TTM) P/E ratio 32.51
EV/FCF (TTM) EV/FCF 28.62
EV/Sales (TTM) EV/Sales 7.19
P/S ratio (TTM) P/S ratio 8.05
P/B ratio (TTM) P/B ratio 6.65
Dividend yield 1.64%
Last dividend (FY23) €0.59
Revenue growth (TTM) Revenue growth 10.02%
Revenue (TTM) Revenue €124.43m
EBIT (operating result TTM) EBIT €35.83m
Free Cash Flow (TTM) Free Cash Flow €31.26m
Cash position €106.98m
EPS (TTM) EPS €0.30
Show more

Is BioGaia a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Financial data from BioGaia

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
124 124
10% 10%
100%
- Direct Costs 34 34
13% 13%
28%
90 90
9% 9%
72%
- Selling and Administrative Expenses 34 34
3% 3%
27%
- Research and Development Expense 14 14
48% 48%
11%
43 43
5% 5%
34%
- Depreciation and Amortization 6.70 6.70
203% 203%
5%
EBIT (Operating Income) EBIT 36 36
7% 7%
29%
Net Profit 31 31
3% 3%
25%

In millions EUR.

Don't miss a Thing! We will send you all news about BioGaia directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Michael Rothschild in 1990 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Theresa Agnew
Employees 225
Founded 1990
Website www.biogaia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today